WIDE MOAT STOCKS COMPARISON

Checking

 

Stock Comparison

Agilent Technologies, Inc. vs AMETEK, Inc.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Agilent Technologies, Inc.

A · New York Stock Exchange

Market cap (USD)$50.8B
Gross margin (TTM)53.8%
Operating margin (TTM)22.2%
Net margin (TTM)19.5%
SectorHealthcare
IndustryDiagnostics and life science tools
CountryUS
Data as of2026-08-23
63/100
Moat score

Weighted across the company's segments.

Full stock profile

Dive deeper into Agilent Technologies, Inc.'s moat claims, evidence, and risks.

View A analysis

AMETEK, Inc.

AME · New York Stock Exchange

Market cap (USD)$54.6B
Gross margin (TTM)36.4%
Operating margin (TTM)26%
Net margin (TTM)19.9%
SectorIndustrials
IndustryElectronic components and instruments
CountryUS
Data as of2026-08-23
25/100
Moat score

Weighted across the company's segments.

Full stock profile

Dive deeper into AMETEK, Inc.'s moat claims, evidence, and risks.

View AME analysis

Comparison highlights

  • Moat score gap: Agilent Technologies, Inc. leads (63 / 100 vs 25 / 100 for AMETEK, Inc.).
  • Segment focus: Agilent Technologies, Inc. has 3 segments (41.9% in Agilent CrossLab); AMETEK, Inc. has 3 segments (46.8% in Process and Analytical Instrumentation).
  • Moat breadth: Agilent Technologies, Inc. has 4 moat types across 2 domains; AMETEK, Inc. has 1 across 1.

Primary market context

Agilent Technologies, Inc.

Agilent CrossLab

Market

Laboratory services, compliance/maintenance, consumables and lab informatics across the lab workflow

Geography

Global

Customer

B2B (installed base labs across pharma, diagnostics, academia and applied markets)

Role

Aftermarket services + consumables + informatics

Revenue share

41.9%

AMETEK, Inc.

Process and Analytical Instrumentation

Market

Process, analytical, metrology, test, measurement and laboratory instrumentation

Geography

Global

Customer

Industrial, semiconductor, energy, pharmaceutical, healthcare, research and laboratory customers

Role

Designer and manufacturer of instruments, sensors, metrology systems and related services

Revenue share

46.8%

Side-by-side metrics

Agilent Technologies, Inc.
AMETEK, Inc.
Ticker / Exchange
A - New York Stock Exchange
AME - New York Stock Exchange
Market cap (USD)
$50.8B
$54.6B
Gross margin (TTM)
53.8%
36.4%
Operating margin (TTM)
22.2%
26%
Net margin (TTM)
19.5%
19.9%
Sector
Healthcare
Industrials
Industry
Diagnostics and life science tools
Electronic components and instruments
HQ country
US
US
Primary segment
Agilent CrossLab
Process and Analytical Instrumentation
Market structure
Competitive
Competitive
Market share
n/a
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
63 / 100
25 / 100
Moat domains
Demand, Supply
Demand
Last update
2026-09-05
2026-09-05

Moat coverage

Shared moat types

Design In Qualification

Agilent Technologies, Inc. strengths

Installed Base ConsumablesService Field NetworkData Workflow Lockin

AMETEK, Inc. strengths

No unique moat types yet.

Segment mix

Agilent Technologies, Inc. segments

Full profile >

Life Sciences and Diagnostics Markets

Competitive

39.2%

Agilent CrossLab

Competitive

41.9%

Applied Markets

Oligopoly

18.9%

AMETEK, Inc. segments

Full profile >

Process and Analytical Instrumentation

Competitive

46.8%

Aerospace and Power

Competitive

29.6%

Automation and Engineered Solutions

Competitive

23.6%

Act on this comparison

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.